{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T05:22:25Z","timestamp":1793424145502,"version":"4.5.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T00:00:00Z","timestamp":1711670400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T00:00:00Z","timestamp":1711670400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005053","name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red en Bioingenier\u00eda, Biomateriales y Nanomedicina","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI17\/01362"],"award-info":[{"award-number":["PI17\/01362"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI15\/0625"],"award-info":[{"award-number":["PI15\/0625"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI15\/0625"],"award-info":[{"award-number":["PI15\/0625"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008666","name":"Fundaci\u00f3 la Marat\u00f3 de TV3","doi-asserted-by":"publisher","award":["303\/C\/2016"],"award-info":[{"award-number":["303\/C\/2016"]}],"id":[{"id":"10.13039\/100008666","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013941","name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red Diabetes y Enfermedades Metab\u00f3licas Asociadas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013941","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["PID2021-122952OB-I00"],"award-info":[{"award-number":["PID2021-122952OB-I00"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>In this study, we evaluated the lipidome alterations caused by type 1 diabetes (T1D) and type 2 diabetes (T2D), by determining lipids significantly associated with diabetes overall and in both sexes, and lipids associated with the glycaemic state.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>An untargeted lipidomic analysis was performed to measure the lipid profiles of 360 subjects (91 T1D, 91 T2D, 74 with prediabetes and 104 controls (CT)) without cardiovascular and\/or chronic kidney disease. Ultra-high performance liquid chromatography-electrospray ionization mass spectrometry (UHPLC-ESI-MS) was conducted in two ion modes (positive and negative). We used multiple linear regression models to (1) assess the association between each lipid feature and each condition, (2) determine sex-specific differences related to diabetes, and (3) identify lipids associated with the glycaemic state by considering the prediabetes stage. The models were adjusted by sex, age, hypertension, dyslipidaemia, body mass index, glucose, smoking, systolic blood pressure, triglycerides, HDL cholesterol, LDL cholesterol, alternate Mediterranean diet score (aMED) and estimated glomerular filtration rate (eGFR); diabetes duration and glycated haemoglobin (HbA1c) were also included in the comparison between T1D and T2D.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 54 unique lipid subspecies from 15 unique lipid classes were annotated. Lysophosphatidylcholines (LPC) and ceramides (Cer) showed opposite effects in subjects with T1D and subjects with T2D, LPCs being mainly up-regulated in T1D and down-regulated in T2D, and Cer being up-regulated in T2D and down-regulated in T1D. Also, Phosphatidylcholines were clearly down-regulated in subjects with T1D. Regarding sex-specific differences, ceramides and phosphatidylcholines exhibited important diabetes-associated differences due to sex. Concerning the glycaemic state, we found a gradual increase of a panel of 1-deoxyceramides from normoglycemia to prediabetes to T2D.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our findings revealed an extensive disruption of lipid metabolism in both T1D and T2D. Additionally, we found sex-specific lipidome changes associated with diabetes, and lipids associated with the glycaemic state that can be linked to previously described molecular mechanisms in diabetes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12933-024-02202-5","type":"journal-article","created":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T14:02:06Z","timestamp":1711720926000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Lipidome characterisation and sex-specific differences in type 1 and type 2 diabetes mellitus"],"prefix":"10.1186","volume":"23","author":[{"given":"Maria","family":"Barranco-Altirriba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N\u00faria","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf J. M.","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin R.","family":"Lloyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Yanes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Capellades","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andris","family":"Jankevics","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Winder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mireia","family":"Falguera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep","family":"Franch-Nadal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warwick B","family":"Dunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Perera-Lluna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esmeralda","family":"Castelblanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didac","family":"Mauricio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,29]]},"reference":[{"key":"2202_CR1","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1055\/s-0034-1366278","volume":"122","author":"AW Kerner","year":"2014","unstructured":"Kerner AW, Br\u00fcckel J, Definition. Classification and diagnosis of diabetes Mellitus. Exp Clin Endocrinol Diabetes. 2014;122:384\u20136. https:\/\/doi.org\/10.1055\/s-0034-1366278.","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"2202_CR2","doi-asserted-by":"publisher","unstructured":"Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. 2019. https:\/\/doi.org\/10.1016\/j.diabres.2019.107843.","DOI":"10.1016\/j.diabres.2019.107843"},{"key":"2202_CR3","doi-asserted-by":"publisher","unstructured":"Rojo-Mart\u00ednez G, Vald\u00e9s S, Soriguer F, Vendrell J, Urrutia I, P\u00e9rez V, et al. Incidence of diabetes mellitus in Spain as results of the nation-wide cohort di@bet.es study. Sci Rep. 2020;10. https:\/\/doi.org\/10.1038\/s41598-020-59643-7.","DOI":"10.1038\/s41598-020-59643-7"},{"key":"2202_CR4","doi-asserted-by":"crossref","unstructured":"Wenk MR. The emerging field of lipidomics. Nat Rev Drug Discov 2005.","DOI":"10.1038\/nrd1776"},{"key":"2202_CR5","doi-asserted-by":"publisher","unstructured":"Castelblanco E, Hern\u00e1ndez M, Ortega E, Amig\u00f3 N, Real J, Granado-Casas M, et al. Outstanding improvement of the advanced lipoprotein profile in subjects with new-onset type 1 diabetes mellitus after achieving optimal glycemic control. Diabetes Res Clin Pract. 2021;182. https:\/\/doi.org\/10.1016\/j.diabres.2021.109145.","DOI":"10.1016\/j.diabres.2021.109145"},{"key":"2202_CR6","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1097\/MED.0000000000000704","volume":"29","author":"EJ Kim","year":"2022","unstructured":"Kim EJ, Ramachandran R, Wierzbicki AS. Lipidomics in diabetes. Curr Opin Endocrinol Diabetes Obes. 2022;29:124\u201330. https:\/\/doi.org\/10.1097\/MED.0000000000000704.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"2202_CR7","doi-asserted-by":"publisher","unstructured":"Suvitaival T. Lipidomic abnormalities during the pathogenesis of type 1 diabetes: a quantitative review. Curr Diab Rep. 2020;20. https:\/\/doi.org\/10.1007\/s11892-020-01326-8.","DOI":"10.1007\/s11892-020-01326-8"},{"key":"2202_CR8","doi-asserted-by":"publisher","unstructured":"Julve J, Genua I, Quifer-Rada P, Yanes \u00d3, Barranco-Altirriba M, Hern\u00e1ndez M, et al. Circulating metabolomic and lipidomic changes in subjects with new-onset type 1 diabetes after optimization of glycemic control. Diabetes Res Clin Pract. 2023;197. https:\/\/doi.org\/10.1016\/j.diabres.2023.110578.","DOI":"10.1016\/j.diabres.2023.110578"},{"key":"2202_CR9","doi-asserted-by":"publisher","unstructured":"Cardner M, Yalcinkaya M, Goetze S, Luca E, Balaz M, Hunjadi M, et al. Structure-function relationships of HDL in diabetes and coronary heart disease. JCI Insight. 2020;5. https:\/\/doi.org\/10.1172\/jci.insight.131491.","DOI":"10.1172\/jci.insight.131491"},{"key":"2202_CR10","doi-asserted-by":"publisher","unstructured":"Barber MN, Risis S, Yang C, Meikle PJ, Staples M, Febbraio MA, et al. Plasma lysophosphatidylcholine levels are reduced in obesity and type 2 diabetes. PLoS ONE. 2012;7. https:\/\/doi.org\/10.1371\/journal.pone.0041456.","DOI":"10.1371\/journal.pone.0041456"},{"key":"2202_CR11","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1210\/jc.2015-3525","volume":"101","author":"S Rauschert","year":"2016","unstructured":"Rauschert S, Uhl O, Koletzko B, Kirchberg F, Mori TA, Huang RC, et al. Lipidomics reveals associations of phospholipids with obesity and insulin resistance in young adults. J Clin Endocrinol Metab. 2016;101:871\u20139. https:\/\/doi.org\/10.1210\/jc.2015-3525.","journal-title":"J Clin Endocrinol Metab"},{"key":"2202_CR12","doi-asserted-by":"publisher","unstructured":"Diamanti K, Cavalli M, Pan G, Pereira MJ, Kumar C, Skrtic S, et al. Intra- and inter-individual metabolic profiling highlights carnitine and lysophosphatidylcholine pathways as key molecular defects in type 2 diabetes. Sci Rep. 2019;9. https:\/\/doi.org\/10.1038\/s41598-019-45906-5.","DOI":"10.1038\/s41598-019-45906-5"},{"key":"2202_CR13","doi-asserted-by":"publisher","unstructured":"Zhong H, Fang C, Fan Y, Lu Y, Wen B, Ren H et al. Lipidomic profiling reveals distinct differences in plasma lipid composition in healthy, prediabetic, and type 2 diabetic individuals. Gigascience 2017;6. https:\/\/doi.org\/10.1093\/gigascience\/gix036.","DOI":"10.1093\/gigascience\/gix036"},{"key":"2202_CR14","doi-asserted-by":"publisher","unstructured":"Ding C, Wang N, Wang Z, Yue W, Li B, Zeng J, et al. Integrated Analysis of Metabolomics and Lipidomics in plasma of T2DM patients with Diabetic Retinopathy. Pharmaceutics. 2022;14. https:\/\/doi.org\/10.3390\/pharmaceutics14122751.","DOI":"10.3390\/pharmaceutics14122751"},{"key":"2202_CR15","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1002\/acn3.51639","volume":"9","author":"F Afshinnia","year":"2022","unstructured":"Afshinnia F, Reynolds EL, Rajendiran TM, Soni T, Byun J, Savelieff MG, et al. Serum lipidomic determinants of human diabetic neuropathy in type 2 diabetes. Ann Clin Transl Neurol. 2022;9:1392\u2013404. https:\/\/doi.org\/10.1002\/acn3.51639.","journal-title":"Ann Clin Transl Neurol"},{"key":"2202_CR16","doi-asserted-by":"publisher","unstructured":"Xu T, Xu X, Zhang L, Zhang K, Wei Q, Zhu L, et al. Lipidomics reveals serum specific lipid alterations in Diabetic Nephropathy. Front Endocrinol (Lausanne). 2021;12. https:\/\/doi.org\/10.3389\/fendo.2021.781417.","DOI":"10.3389\/fendo.2021.781417"},{"key":"2202_CR17","doi-asserted-by":"publisher","unstructured":"Ohkuma T, Peters SAE, Woodward M. Sex differences in the association between diabetes and cancer: a systematic review and meta-analysis of 121 cohorts including 20 million individuals and one million events. Diabetologia. 2018. https:\/\/doi.org\/10.1007\/s00125-018-4664-5.","DOI":"10.1007\/s00125-018-4664-5"},{"key":"2202_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12933-015-0196-1","volume":"14","author":"N Alonso","year":"2015","unstructured":"Alonso N, Traveset A, Rubinat E, Ortega E, Alcubierre N, Sanahuja J, et al. Type 2 diabetes-associated carotid plaque burden is increased in patients with retinopathy compared to those without retinopathy. Cardiovasc Diabetol. 2015;14:1\u20139. https:\/\/doi.org\/10.1186\/s12933-015-0196-1.","journal-title":"Cardiovasc Diabetol"},{"key":"2202_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12933-018-0706-z","volume":"17","author":"M Carbonell","year":"2018","unstructured":"Carbonell M, Castelblanco E, Valldeperas X, Betriu \u00c0, Traveset A, Granado-Casas M, et al. Diabetic retinopathy is associated with the presence and burden of subclinical carotid atherosclerosis in type 1 diabetes. Cardiovasc Diabetol. 2018;17:1\u201310. https:\/\/doi.org\/10.1186\/s12933-018-0706-z.","journal-title":"Cardiovasc Diabetol"},{"key":"2202_CR20","doi-asserted-by":"publisher","unstructured":"Vilanova MB, Falguera M, Marsal JR, Rubinat E, Alcubierre N, Catelblanco E, et al. Prevalence, clinical features and risk assessment of pre-diabetes in Spain: the prospective Mollerussa cohort study. BMJ Open. 2017;7. https:\/\/doi.org\/10.1136\/bmjopen-2016-015158.","DOI":"10.1136\/bmjopen-2016-015158"},{"key":"2202_CR21","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.numecd.2015.04.009","volume":"25","author":"M Catalan","year":"2015","unstructured":"Catalan M, Herreras Z, Pinyol M, Sala-Vila A, Amor AJ, de Groot E, et al. Prevalence by sex of preclinical carotid atherosclerosis in newly diagnosed type 2 diabetes. Nutr Metabolism Cardiovasc Dis. 2015;25:742\u20138. https:\/\/doi.org\/10.1016\/j.numecd.2015.04.009.","journal-title":"Nutr Metabolism Cardiovasc Dis"},{"key":"2202_CR22","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"9","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang Y, Castro AF III, Feldman HI, et al. A New equation to Estimate glomerular filtration rate. Ann Intern Med. 2009;9:604\u201312.","journal-title":"Ann Intern Med"},{"key":"2202_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/nu13010252","volume":"13","author":"M Falguera","year":"2021","unstructured":"Falguera M, Castelblanco E, Rojo-L\u00f3pez MI, Vilanova MB, Real J, Alcubierre N, et al. Mediterranean diet and healthy eating in subjects with prediabetes from the mollerussa prospective observational cohort study. Nutrients. 2021;13:1\u201310. https:\/\/doi.org\/10.3390\/nu13010252.","journal-title":"Nutrients"},{"key":"2202_CR24","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.2337\/dc17-S005","volume":"40","author":"American Diabetes Association","year":"2017","unstructured":"American Diabetes Association. Classification and diagnosis of diabetes. Diabetes Care. 2017;40:S11\u201324. https:\/\/doi.org\/10.2337\/dc17-S005.","journal-title":"Diabetes Care"},{"key":"2202_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nbt.2377.A","volume":"30","author":"MC Chambers","year":"2012","unstructured":"Chambers MC, et al. A cross-platform toolkit for Mass Spectrometry and Proteomics. Businesslive. 2012;30:1. https:\/\/doi.org\/10.1038\/nbt.2377.A.","journal-title":"Businesslive"},{"key":"2202_CR26","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1021\/ac051437y","volume":"78","author":"CA Smith","year":"2006","unstructured":"Smith CA, Want EJ, O\u2019Maille G, Abagyan R, Siuzdak G. XCMS: Processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification. Anal Chem. 2006;78:779\u201387. https:\/\/doi.org\/10.1021\/ac051437y.","journal-title":"Anal Chem"},{"key":"2202_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12859-015-0562-8","volume":"16","author":"G Libiseller","year":"2015","unstructured":"Libiseller G, Dvorzak M, Kleb U, Gander E, Eisenberg T, Madeo F, et al. IPO: a tool for automated optimization of XCMS parameters. BMC Bioinformatics. 2015;16:1\u201310. https:\/\/doi.org\/10.1186\/s12859-015-0562-8.","journal-title":"BMC Bioinformatics"},{"key":"2202_CR28","doi-asserted-by":"publisher","first-page":"5147","DOI":"10.1007\/s00216-013-6856-7","volume":"405","author":"JA Kirwan","year":"2013","unstructured":"Kirwan JA, Broadhurst DI, Davidson RL, Viant MR. Characterising and correcting batch variation in an automated direct infusion mass spectrometry (DIMS) metabolomics workflow. Anal Bioanal Chem. 2013;405:5147\u201357. https:\/\/doi.org\/10.1007\/s00216-013-6856-7.","journal-title":"Anal Bioanal Chem"},{"key":"2202_CR29","unstructured":"Jankevics A, Lloyd GR, Weber RJM. pmp: Peak Matrix Processing and signal batch correction for metabolomics datasets 2021."},{"key":"2202_CR30","unstructured":"Lloyd GR, Weber RJM. structToolbox: Data processing & analysis tools for Metabolomics and other omics 2022."},{"key":"2202_CR31","doi-asserted-by":"publisher","first-page":"5551","DOI":"10.1093\/bioinformatics\/btaa1031","volume":"36","author":"GR Lloyd","year":"2020","unstructured":"Lloyd GR, Jankevics A, Weber RJM. Struct: an R\/Bioconductor-based framework for standardized metabolomics data analysis and beyond. Bioinformatics. 2020;36:5551\u20132. https:\/\/doi.org\/10.1093\/bioinformatics\/btaa1031.","journal-title":"Bioinformatics"},{"key":"2202_CR32","doi-asserted-by":"crossref","unstructured":"Subirana I, H\u00e9ctor C, Cresib S, Vila J. Building Bivariate Tables: The compareGroups Package for R. vol. 57. 2014.","DOI":"10.18637\/jss.v057.i12"},{"key":"2202_CR33","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing 2021."},{"key":"2202_CR34","doi-asserted-by":"publisher","first-page":"4281","DOI":"10.1021\/ac051632c","volume":"78","author":"F Dieterle","year":"2006","unstructured":"Dieterle F, Ross A, Schlotterbeck G, Senn H. Probabilistic quotient normalization as robust method to account for dilution of complex biological mixtures. Application in1H NMR metabonomics. Anal Chem. 2006;78:4281\u201390. https:\/\/doi.org\/10.1021\/ac051632c.","journal-title":"Anal Chem"},{"key":"2202_CR35","unstructured":"Rousset X, Vaisman B, Amar M, Sethi AA, Remaley AT. Lecithin:Cholesterol Acyltransferase: From Biochemistry to Role in Cardiovascular Disease. n.d."},{"key":"2202_CR36","doi-asserted-by":"publisher","first-page":"3951","DOI":"10.2337\/db13-0215","volume":"62","author":"D La Torre","year":"2013","unstructured":"La Torre D, Sepp\u00e4nen-Laakso T, Larsson HE, Hy\u00f6tyl\u00e4inen T, Ivarsson SA, Lernmark \u00c5, et al. Decreased cord-blood phospholipids in young age-at-onset type 1 diabetes. Diabetes. 2013;62:3951\u20136. https:\/\/doi.org\/10.2337\/db13-0215.","journal-title":"Diabetes"},{"key":"2202_CR37","doi-asserted-by":"publisher","first-page":"2975","DOI":"10.1084\/JEM.20081800","volume":"205","author":"M Ore\u0161i\u010d","year":"2008","unstructured":"Ore\u0161i\u010d M, Simell S, Sysi-Aho M, N\u00e4nt\u00f6-Salonen K, Sepp\u00e4nen-Laakso T, Parikka V, et al. Dysregulation of lipid and amino acid metabolism precedes islet autoimmunity in children who later progress to type 1 diabetes. J Exp Med. 2008;205:2975. https:\/\/doi.org\/10.1084\/JEM.20081800.","journal-title":"J Exp Med"},{"key":"2202_CR38","doi-asserted-by":"publisher","unstructured":"Ma\u0142achowska B, Pietrowska K, M\u0142ynarski W, Szadkowska A, Kr\u0119towski A, Ciborowski M, et al. Multi-timepoint metabolic fingerprinting of a Post-episode period of hypoglycemia and ketoacidosis among children with type 1 diabetes. Front Mol Biosci. 2022;9. https:\/\/doi.org\/10.3389\/fmolb.2022.869116.","DOI":"10.3389\/fmolb.2022.869116"},{"key":"2202_CR39","doi-asserted-by":"publisher","unstructured":"Floegel A, Stefan N, Yu Z, M\u00fchlenbruch K, Drogan D, Joost H-G et al. Identification of serum metabolites Associated with risk of type 2 diabetes using a targeted Metabolomic Approach n.d. https:\/\/doi.org\/10.2337\/db12-0495.","DOI":"10.2337\/db12-0495"},{"key":"2202_CR40","doi-asserted-by":"publisher","first-page":"66","DOI":"10.31989\/bchd.v3i4.690","volume":"3","author":"A Rajab","year":"2020","unstructured":"Rajab A, Rabizadeh S, Bitaraf M, Ghanei A, Esteghamati A, Nakhjavani M, et al. Lecithin-cholesterol acyltransferase (LCAT) activity is lower in patients with type 2 diabetes in the presence of metabolic syndrome. Bioact Compd Health Dis. 2020;3:66\u201373. https:\/\/doi.org\/10.31989\/bchd.v3i4.690.","journal-title":"Bioact Compd Health Dis"},{"key":"2202_CR41","unstructured":"Ghanei A, Esfahanian F, Esteghamati A, Nakhjavani M. Lecithin cholesterol acyltransferase activity is decreased in type 2 diabetes mellitus. 2007."},{"key":"2202_CR42","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.diabres.2008.01.018","volume":"81","author":"M Nakhjavani","year":"2008","unstructured":"Nakhjavani M, Esteghamati A, Esfahanian F, Ghanei A, Rashidi A, Hashemi S. HbA1c negatively correlates with LCAT activity in type 2 diabetes. Diabetes Res Clin Pract. 2008;81:38\u201341. https:\/\/doi.org\/10.1016\/j.diabres.2008.01.018.","journal-title":"Diabetes Res Clin Pract"},{"key":"2202_CR43","doi-asserted-by":"publisher","first-page":"631","DOI":"10.2217\/17460875.1.5.631","volume":"1","author":"RR Brenner","year":"2006","unstructured":"Brenner RR. Antagonism between type 1 and type 2 diabetes in unsaturated fatty acid biosynthesis. Future Lipidol. 2006;1:631\u201340. https:\/\/doi.org\/10.2217\/17460875.1.5.631.","journal-title":"Future Lipidol"},{"key":"2202_CR44","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1007\/s13238-017-0423-5","volume":"9","author":"JM Dean","year":"2018","unstructured":"Dean JM, Lodhi IJ. Structural and functional roles of ether lipids. Protein Cell. 2018;9:196\u2013206. https:\/\/doi.org\/10.1007\/s13238-017-0423-5.","journal-title":"Protein Cell"},{"key":"2202_CR45","doi-asserted-by":"publisher","unstructured":"Hannich JT, Loizides-Mangold U, Sinturel F, Harayama T, Vandereycken B, Saini C, et al. Ether lipids, sphingolipids and toxic 1-deoxyceramides as hallmarks for lean and obese type 2 diabetic patients. Acta Physiol. 2021;232. https:\/\/doi.org\/10.1111\/apha.13610.","DOI":"10.1111\/apha.13610"},{"key":"2202_CR46","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.2337\/dc19-0100","volume":"42","author":"J Lu","year":"2019","unstructured":"Lu J, ManLam S, Wan Q, Shi L, Huo Y, Chen L, et al. High-coverage targeted lipidomics reveals novel serum lipid predictors and lipid pathway dysregulation antecedent to type 2 diabetes onset in normoglycemic Chinese adults. Diabetes Care. 2019;42:2117\u201326. https:\/\/doi.org\/10.2337\/dc19-0100.","journal-title":"Diabetes Care"},{"key":"2202_CR47","doi-asserted-by":"publisher","unstructured":"Gonzalez-Covarrubias V. Lipidomics in longevity and healthy aging n.d. https:\/\/doi.org\/10.1007\/s10522-013-9450-7.","DOI":"10.1007\/s10522-013-9450-7"},{"key":"2202_CR48","doi-asserted-by":"publisher","unstructured":"Roszczyc-Owsiejczuk K, Zabielski P. Sphingolipids as a culprit of mitochondrial dysfunction in insulin resistance and type 2 diabetes. Front Endocrinol (Lausanne). 2021;12. https:\/\/doi.org\/10.3389\/fendo.2021.635175.","DOI":"10.3389\/fendo.2021.635175"},{"key":"2202_CR49","doi-asserted-by":"publisher","first-page":"296","DOI":"10.3390\/healthcare3020296","volume":"3","author":"Q Shen","year":"2015","unstructured":"Shen Q, Pierce JD. Supplementation of coenzyme Q10 among patients with type 2 diabetes mellitus. Healthc (Switzerland). 2015;3:296\u2013309. https:\/\/doi.org\/10.3390\/healthcare3020296.","journal-title":"Healthc (Switzerland)"},{"key":"2202_CR50","doi-asserted-by":"publisher","unstructured":"Mielke MM, Venkata V, Bandaru R, Han D, An Y, Resnick SM et al. Demographic and clinical variables affecting mid-to late-life trajectories of plasma ceramide and dihydroceramide species n.d. https:\/\/doi.org\/10.1111\/acel.12369.","DOI":"10.1111\/acel.12369"},{"key":"2202_CR51","doi-asserted-by":"publisher","unstructured":"Muilwijk M, Callender N, Goorden S, Vaz FM, van Valkengoed IGM. Sex differences in the association of sphingolipids with age in Dutch and south Asian Surinamese living in Amsterdam, the Netherlands. Biol Sex Differ 2021. https:\/\/doi.org\/10.1186\/s13293-020-00353-0.","DOI":"10.1186\/s13293-020-00353-0"},{"key":"2202_CR52","doi-asserted-by":"publisher","unstructured":"Arosio B, Corbi G, Davinelli S, Giordano V, Liccardo D, Rapacciuolo A, et al. Sex differences in Cardiovascular diseases: a matter of Estrogens, Ceramides, and sphingosine 1-Phosphate. Int J Mol Sci. 2022;23. https:\/\/doi.org\/10.3390\/ijms23074009.","DOI":"10.3390\/ijms23074009"},{"key":"2202_CR53","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/J.MATURITAS.2018.08.009","volume":"117","author":"R Slopien","year":"2018","unstructured":"Slopien R, Wender-Ozegowska E, Rogowicz-Frontczak A, Meczekalski B, Zozulinska-Ziolkiewicz D, Jaremek JD, et al. Menopause and diabetes: EMAS clinical guide. Maturitas. 2018;117:6\u201310. https:\/\/doi.org\/10.1016\/J.MATURITAS.2018.08.009.","journal-title":"Maturitas"},{"key":"2202_CR54","doi-asserted-by":"publisher","unstructured":"Kautzky-Willer A, Harreiter J, Pacini G. Sex and gender differences in risk, pathophysiology and complications of type 2 Diabetes Mellitus 2016. https:\/\/doi.org\/10.1210\/er.2015-1137.","DOI":"10.1210\/er.2015-1137"},{"key":"2202_CR55","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1016\/j.metabol.2014.07.001","volume":"63","author":"RL Klein","year":"2014","unstructured":"Klein RL, Hammad SM, Baker NL, Hunt KJ, Al Gadban MM, Cleary PA, et al. Decreased plasma levels of select very long chain ceramide species are associated with the development of nephropathy in type 1 diabetes. Metabolism. 2014;63:1287\u201395. https:\/\/doi.org\/10.1016\/j.metabol.2014.07.001.","journal-title":"Metabolism"},{"key":"2202_CR56","doi-asserted-by":"publisher","unstructured":"Raile K, Galler A, Hofer S, Herbst A, Dunstheimer D, Busch P et al. Diabetic Nephropathy in 27,805 children, adolescents, and adults with type 1 diabetes effect of diabetes duration, A1C, hypertension, dyslipidemia, diabetes onset, and sex 2007. https:\/\/doi.org\/10.2337\/dc07-0282.","DOI":"10.2337\/dc07-0282"},{"key":"2202_CR57","doi-asserted-by":"publisher","unstructured":"Saulnier-Blache J-S, Feigerlova E, Halimi JM, Gourdy P, Roussel R, Guerci B et al. Urinary lysophopholipids are increased in diabetic patients with nephropathy 2017. https:\/\/doi.org\/10.1016\/j.jdiacomp.2017.04.024.","DOI":"10.1016\/j.jdiacomp.2017.04.024"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-024-02202-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-024-02202-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-024-02202-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T14:02:20Z","timestamp":1711720940000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-024-02202-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,29]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2202"],"URL":"https:\/\/doi.org\/10.1186\/s12933-024-02202-5","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,29]]},"assertion":[{"value":"7 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the local ethics committee of the University Hospital Germans Trias i Pujol (PI-15-147), following the principles of the Declaration of Helsinki. All participants provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Prof. Mauricio is a co-author of this study and an Editorial Board member of the Cardiovascular diabetology journal. He was not involved in handling this manuscript during the submission and the review processes.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"109"}}